酸化二窒素

Nitrous Oxide

HCID 948CAS 10024-97-2

基本情報

標準SMILES
[N-]=[N+]=O
InChIKey
GQPLMRYTRLFLPF-UHFFFAOYSA-N
分子式
N2O
平均分子量
44.013 g/mol
単同位体質量
44.00106262

概要

Nitrous Oxide can cause developmental toxicity and female reproductive toxicity according to The National Institute for Occupational Safety and Health (NIOSH).

名称と識別子

優先名称
Nitrous Oxide
IUPAC
nitrous oxide
現地名
酸化二窒素
英語名
Nitrous oxide
分子式
N2O
分子量
44.01

名称と別名

nitrous oxideLaughing gasDinitrogen oxideDinitrogen monoxideFactitious airNitrogen oxide (N2O)10024-97-2Hyponitrous acid anhydrideNitrogen hypoxideStickdioxydoxyde nitreuxOxido nitroso
名称をさらに表示
亜酸化窒素酸化二窒素笑気酸化窒素(I)笑気ガス一酸化二窒素亜酸化窒素 (JP17)一酸化二窒素(亜酸化窒素)N2On20LachgasNitralnitros oxideoxidonitroso
Gas, Laughingprotoxyde d'azoteNitrous oxide, compressedOxide, NitrousDistickstoffmonoxidFEMA No. 2779Nitrogenum oxygenatumProtoxide of nitrogen

データベース識別子

CAS
10024-97-2、2227102-37-4、97485-25-1
PubChem CID
948
DTXSID
DTXSID8021066
ChEMBL
CHEMBL1234579
ChEBI
CHEBI:17045
UNII
K50XQU1029
EC Number
233-032-0
Nikkaji
J2.255.097G

物性

構造計算による物性

XLogP
0.5
極性表面積
19.1 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
0
重原子数
3

実験および物理化学的性質

Chemical ClassesToxic Gases & Vapors -> Other Toxic Gases & Vapors
DrugsDEA NFLIS-Drug Category -> Analgesics
CosmeticsPropellant
SpringerMaterials PropertiesGibbs energy
LogP · 2 件

log Kow = 0.36

0.36

Odor · 2 件

Slightly sweetish

Weak, pleasant odor

物理化学的性質

融点
91 °C · −91 °C(lit.)
沸点
88 °C · −88 °C(lit.)
比重(密度)
1.23 g/cm3 · 1.23 g/cm3 (-89 ºC)
蒸気密度
1.53 · 1.53 (15 °C, vs air)
蒸気圧
51.7 mm · 51.7 mm Hg ( 21 °C)
屈折率
1.38 · 1.380

化学的性質

化学的特性Nitrous oxide is a colorless gas. Slightly sweet odor. Shipped as a liquefied compressed gas.

安全と法規制

GHS分類

GHS Classification · 6 件

Danger

H270 (100%): May cause or intensify fire; oxidizer [Danger Oxidizing gases]

P220, P244, P261, P271, P282, P304+P340, P319, P336+P317, P370+P376, P403, P403+P233, P405, P410+P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 663 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H270: May cause or intensify fire; oxidizer [Danger Oxidizing gases]

危険有害性情報

Regulatory Information · 6 件

Chemical: Nitrogen oxide, (N2O)

Hazard Traits - Developmental Toxicity; Reproductive Toxicity

Nitrogen oxide (N2O) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Nitrogen oxide (N2O) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Dinitrogen oxide (EC: 233-032-0)

Nitrous oxide: HSNO Approval: HSR001065 Approved with controls

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

DOT Label · 2 件

Non-Flammable Gas Oxidizer

Non-Flammable Gas Oxidizer

Fire Hazards · 5 件

Behavior in Fire: Will support combustion, and may increase intensity of fire. Containers may explode when heated. (USCG, 1999)

Excerpt from ERG Guide 122 [Gases - Oxidizing (Including Refrigerated Liquids)]:

· Substance does not burn but will support combustion.

· Substance does not burn but will support combustion.

Not combustible but enhances combustion of other substances. Gives off irritating or toxic fumes (or gases) in a fire. Risk of fire and explosion. See Chemical Dangers.

Fire Potential · 3 件

Spontaneous ignition occurs when nitrous oxide and lithium hydride or hydrazine are mixed.

Amorphous boron ignites when heated in dry nitrous oxide.

Does not burn but is flammable by chemical reaction and supports combustion.

Health Hazards · 4 件

Inhalation causes intense analgesia; concentrations of over 40-60% cause loss of consciousness preceded by hysteria. Contact of liquid with eyes or skin causes frostbite burn. (USCG, 1999)

Excerpt from ERG Guide 122 [Gases - Oxidizing (Including Refrigerated Liquids)]:

· Vapors may cause dizziness or asphyxiation without warning, especially when in closed or confined areas.

· Vapors may cause dizziness or asphyxiation without warning, especially when in closed or confined areas.

Hazards Summary · 1 件

Nitrous oxide is a simple asphyxiant; it has caused neuropathy when abused for its euphoric effects. The TLV basis is CNS impairment, hematologic effect, and embryo/fetal damage. Rats exposed for 2 or more days to 80% NO and 20% O2 have altered hematopoiesis. At 1000 ppm, NO inactivates vitamin B12. [ACGIH] Possible frostbite from contact with liquid; [NIOSH] In substance abuse cases with peripheral neuropathy, nitrous oxide was administered at 300,000 to 800,000 ppm (30-80%) for 30-60 minutes per day, 2-7 days a week for 3 months to several years. [CHEMINFO]

安全と保護具

Fire Fighting · 3 件

Excerpt from ERG Guide 122 [Gases - Oxidizing (Including Refrigerated Liquids)]:

Excerpt from ERG Guide 122 [Gases - Oxidizing (Including Refrigerated Liquids)]:

In case of fire in the surroundings, use appropriate extinguishing media. In case of fire: keep cylinder cool by spraying with water. Combat fire from a sheltered position.

First Aid Measures · 3 件

Fresh air, rest. Refer for medical attention.

ON FROSTBITE: rinse with plenty of water, do NOT remove clothes. Refer for medical attention .

First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.

Accidental Release Measures · 4 件

· CALL 911. Then call emergency response telephone number on shipping paper. If shipping paper not available or no answer, refer to appropriate telephone number listed on the inside back cover.

· Keep combustibles (wood, paper, oil, etc.) away from spilled material.

· CALL 911. Then call emergency response telephone number on shipping paper. If shipping paper not available or no answer, refer to appropriate telephone number listed on the inside back cover.

· Keep combustibles (wood, paper, oil, etc.) away from spilled material.

First Aid · 5 件

Excerpt from NIOSH Pocket Guide for Nitrous oxide:

Excerpt from NIOSH Pocket Guide for Nitrous oxide:

General First Aid:

General First Aid:

(General first aid procedures)

Safe StorageFireproof if in building. Separated from reducing agents and combustible substances. Cool.
Firefighting Hazards · 2 件

Nitrous oxide is an oxidizer and will increase the intensity of any fire.

Exposure of the container to prolonged heat or fire can cause it to rupture violently and rocket.

毒性情報

Body BurdenTherapeutic nitrous oxide blood-level 290-440 mg/L, 29-44 mg/dL
Interactions · 5 件

When administered alone, nitrous oxide can significantly increase cerebral blood flow and intracranial pressure. This cerebral vasodilatory capacity of /nitrous oxide/ is significantly attenuated by the simultaneous administration of intravenous agents such as opiates and propofol. By contrast, the combination of /nitrous oxide/ and inhaled agents results in greater vasodilation than the administration of the inhaled agent alone at equivalent anesthetic depth.

The abuse-related behavioral effects produced by nitrous oxide (N2O) gas have been suggested as being unique compared with other abused inhalants. The drug discrimination paradigm in animals can be used to study subjective effects of drugs in humans and to test this hypothesis. The goals of the present experiment were to establish N2O discrimination in mice and to compare its discriminative stimulus effects with those of abused volatile vapors and vapor anesthetics. Sixteen B6SJLF1/J mice were trained to discriminate between 10 min of exposure to 60% N2O+40% oxygen (O2) and 10 min of exposure to 100% O2. The time course of N2O discrimination was examined, followed by cross-substitution testing with abused vapors, volatile anesthetics, ethanol, D-amphetamine, and 2-butanol. Mice acquired the ability to discriminate between N2O and O2 in 40 days. N2O fully substituted for 10 min of exposure to 60% N2O in a concentration-dependent manner. Full substitution required 7 min of 60% N2O exposure, but the offset of stimulus effects following the cessation of exposure was more rapid. The aromatic hydrocarbon toluene almost fully substituted for N2O. 1,1,1-Trichloroethane, methoxyflurane, isoflurane, and ethanol showed lesser degrees of substitution. D-amphetamine and the odorant 2-butanol did not substitute for N2O. Given the varying degrees of incomplete substitution by test compounds, the discriminative stimulus properties of N2O and, perhaps, its subjective effects in humans are probably not unique. As none of the inhalants tested fully mimicked N2O, its overall effects may include one or more novel stimulus components.

In recent years, the glutamate theory of alcoholism has emerged as a major theory in the addiction research field and N-methyl-d-aspartate (NMDA) receptors have been shown to play a major role in alcohol craving and relapse. The NMDA receptors are considered as the primary site of action of the anesthetic gases xenon (Xe) and nitrous oxide (N2O). Despite the rapid on/off kinetics of these gases on the NMDA receptor, a brief gas exposure can induce an analgesic or antireward effect lasting several days. The aim of this study was to examine the effect of both Xe and N2O on alcohol-seeking and relapse-like drinking behavior (measured as the alcohol deprivation effect) in Wistar rats. We used 2 standard procedures-the alcohol deprivation model with repeated deprivation phases and the cue-induced reinstatement model of alcohol seeking-to study the effect of 2 brief gas exposures of either Xe, N2O, or control gas on relapse-like drinking and alcohol-seeking behavior. Here, we show that exposure to Xe during the last 24 hours of abstinence produced a trend toward reduced ethanol intake during the first alcohol re-exposure days. In addition, Xe gas exposure significantly decreased the cue-induced reinstatement of alcohol-seeking behavior. N2 O had no effect on either behavior. Xe reduces alcohol-seeking behavior in rats and may therefore also interfere with craving in human alcoholics.

The displacement curves for air, nitrogen, and oxygen gave only a single point of inflection and IC50 values of 20, 9.2, and 7.8 nmol, respectively, on in vitro (3)H-naloxone binding to rat forebrain (strain not given). Nitrous oxide at 100% and 50% caused an extra inflection point in displacement curve giving rise to 2 IC50 values of 62.9 and 57.8 nmol (for lower affinity receptor) and 0.06 and 0.06 nmol (for higher affinity receptor) for 100 and 50%, respectively.

For more Interactions (Complete) data for Nitrous oxide (26 total), please visit the HSDB record page.

Target Organsrespiratory system, central nervous system, reproductive system
Environmental FateATMOSPHERIC FATE: Nitrous oxide has an atmospheric lifetime of 114 years. The Global Warming Potential = 298 (100-year)(1).
Adverse Effects · 2 件

Neurotoxin - Sensorimotor

Adverse effects of nitrous include:

Exposure Routes · 2 件

The substance can be absorbed into the body by inhalation.

inhalation, skin and/or eye contact (liquid)

法規制情報

FDA RequirementsSubstance added directly to human food affirmed as generally recognized as safe (GRAS).

安全データ

F
4.5-31
OEB
A
OEL
TWA: 25 ppm (46 mg/m3) (TWA: over the time exposed) [*Note: REL for exposure to waste anesthetic gas.]
wgk
1
tsca
TSCA listed
rtecs
QX1350000

化学と産業

薬理情報

ATC Code · 4 件

N01AX13

N - Nervous system

QN - Nervous system

N01AX13

Mechanism of Action · 6 件

Findings to date indicate that nitrous oxide induces opioid peptide release in the brain stem leading to the activation of descending noradrenergic neurones, which results in modulation of the nociceptive process in the spinal cord. Several receptor–effector mechanisms including dopamine receptors, α2 adrenoceptors, benzodiazepine receptors and -methyl- -aspartate (NMDA) receptors have been implicated although the relationship of one with the other is not known.

Nitrous oxide (N2O) gas is a widely used anesthetic adjunct in dentistry and medicine that is also commonly abused. Studies have shown that N2O alters the function of the N-methyl-d-aspartate (NMDA), GABAA, opioid, and serotonin receptors among others. However, the receptors systems underlying the abuse-related central nervous system effects of N2O are unclear. The present study explores the receptor systems responsible for producing the discriminative stimulus effects of N2O. B6SJLF1/J male mice trained to discriminate 10 minutes of exposure to 60% N2O + 40% oxygen versus 100% oxygen served as subjects. Both the high-affinity NMDA receptor channel blocker (+)-MK-801 maleate [(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] and the low-affinity blocker memantine partially mimicked the stimulus effects of N2O. Neither the competitive NMDA antagonist, CGS-19755 (cis-4-[phosphomethyl]-piperidine-2-carboxylic acid), nor the NMDA glycine-site antagonist, L701-324 [7-chloro-4-hydroxy-3-(3-phenoxy)phenyl-2(1H)-quinolinone], produced N2O-like stimulus effects. A range of GABAA agonists and positive modulators, including midazolam, pentobarbital, muscimol, and gaboxadol (4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol), all failed to produce N2O-like stimulus effects. The mu-, kappa-, and delta-opioid agonists, as well as 5-hydroxytryptamine (serotonin) 1B/2C (5-HT1B/2C) and 5-HT1A agonists, also failed to produce N2O-like stimulus effects. Ethanol partially substituted for N2O. Both (+)-MK-801 and ethanol but not midazolam pretreatment also significantly enhanced the discriminative stimulus effects of N2O. Our results support the hypothesis that the discriminative stimulus effects of N2O are at least partially mediated by NMDA antagonist effects similar to those produced by channel blockers. However, as none of the drugs tested fully mimicked the stimulus effects of N2O, other mechanisms may also be involved.

N2O interferes with vitamin B12 and folate metabolism. This impairs production of methionine (from homocysteine), used to form tetrahydrofolate and thymidine during DNA synthesis.

Nitrous oxide is 35 times more soluble than nitrogen. The gas exchanges with nitrogen and diffuses into hollow viscera and body spaces potentially containing air, such as pneumothorax, paranasal sinuses and pneumoperitoneum, or into the cerebral ventricles following pneumoencephalography. This expands the body of trapped air and increases the pressure within such closed spaces. When administration is discontinued, nitrous oxide is released into the alveoli, diluting the alveolar gases. A reduction in alveolar oxygen tension may result. This is referred to as diffusion anoxia. Because of the high concentration of nitrous oxide required to produce and maintain anesthesia, hypoxia is an unavoidable accompaniment to its use. During induction with high concentrations of nitrous oxide, the oxygen in the lungs is rapidly used up and the anoxia with increased respiratory effort causes rapid depletion of carbon dioxide in the tissues. Absence of carbon dioxide and depression of the medullary centers by the anesthetic quickly lead to respiratory failure, and rarely, the patient's cerebral function fails to recover from cerebral damage caused by the prolonged anoxia. The brain suffers anoxia from the very beginning of the administration of the gas, and not from just the moment of cessation of respiratory movements. Thus, the period of anoxia may be five minutes or more, sufficient to cause permanent brain damage in the susceptible individual. The arbitrary "safe period" of eight minutes may be too long for some patients.

Nitrous oxide induces inconsistent changes in the basal levels of the thalamic nuclei. The mechanism of analgesia is believed to involve a direct intraspinal anti-nociceptive action rather than depression of limbic function. In the brain stem, responses evoked by pain stimulation are depressed, although the extent of depression may be variable. Nitrous oxide in anesthetic doses increases cerebral blood flow and intracranial pressure.

For more Mechanism of Action (Complete) data for Nitrous oxide (7 total), please visit the HSDB record page.

Metabolism/MetabolitesNitrous oxide is not biotransformed by enzymatic action in human tissue ... .
MeSH Pharmacological Classification · 2 件

Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173)

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Absorption, Distribution and Excretion · 5 件

The blood/gas partition coefficient is low and most of the inhaled nitrous oxide is rapidly eliminated through the lungs, though small amounts diffuse through the skin.

/Nitrous oxide/ is highly lipid soluble and rapidly absorbed and distributed throughout the body, particularly the vessel-rich regions, including the brain, heart, kidney, splanchnic circulation, and endocrine glands. The rate of nitrous oxide uptake during the first 1 or 2 min is about 1.0 L/min (at an inspired concentrations of 80%), with later uptake inversely proportional to the square root of time. /Nitrous oxide/ is relatively nonreactive and poorly soluble in blood. ... Little hepatic or renal metabolism is detectable in experimental animals, although intestinal bacteria can reduce small quantities of inhaled /nitrous oxide/ to nitrogen gas. Small amounts of inhaled /nitrous oxide/ are also eliminated through the skin and urine.

Placental transmission data: time to appear in fetus, 6 minutes; fetal/maternal concentration ratio, 0.6. /From table/

Concentration for surgical anesthesia: nitrous oxide-inhaled concn 80-85%; blood level 30-50 mg/100 mL; partition coefficients: blood/air 0.47; brain/blood 1.1; oil/blood 3; clearance rate of blood passing lung (alveolar tension) 63%.

Nitrous oxide is almost completely eliminated by the lungs, with some minimal diffusion through the skin. Nitrous oxide is not biotransformed by enzymatic action in human tissue, and 99.9% of absorbed nitrous oxide is eliminated unchanged.

Cellular LocationsCytoplasm

用途と製造

Uses · 6 件

Nitrous oxide has been used as an anesthetic since 1844. It has also been used as a foaming agent for whipped cream, as an oxidant in organic chemical production and as a component of rocket fuel. Occupational exposures have been measured in the 400 to 3000 ppm range without anesthetic waste gas scavenging and 50 ppm with waste gas scavenging. [ACGIH]

To oxidize organic compounds at temperatures greater than 300 °C; to make nitrites from alkali metals at their boiling points; in rocket fuel formulations (with carbon disulfide); in the preparation of whipped cream.

Anesthetic in dentistry and surgery, propellant gas in food aerosols, leak detection.

Agent in detection of leaks in natural gas pipelines

In the munitions-explosives industry, as propellant.

For more Uses (Complete) data for Nitrous oxide (7 total), please visit the HSDB record page.

ImpuritiesThe chief impurity of the commercial product is /nitrogen/ gas, although /nitrogen dioxide/, /nitrogen/, /oxygen/, and /carbon dioxide/ may also be present.
U.S. Production · 3 件

2023: 100,000 - <250,000 lb

Production volume for non-confidential chemicals reported under the 2006 Inventory Update Rule. Chemical: Nitrogen oxide. Aggregated National Production Volume: 10 to < 50 million pounds.

Non-confidential 2012 Chemical Data Reporting (CDR) information on the production and use of chemicals manufactured or imported into the United States. Chemical: Nitrogen oxide. National Production Volume: Withheld.

Consumption PatternsAbout 80-90% in combination with oxygen as a general volatile medical anesthetic; 10-20% principally as a propellant for food aerosols, and also as an agent in detection of leaks in natural gas pipelines (1972).
Consumer UsesSemiconductor and photovoltaic agent
Industry UsesOther
応用分野 · 7 件

解説酸化二窒素,室温で無色の気体.融点-90.9 ℃,沸点-88.6 ℃.液体,固体ともに無色.N-N-O直線構造(N-N0.112 nm,N-O0.119 nm)で双極子モーメント0.17 D.室温では化学的に安定である.海洋や土壌,窒素肥料や工業活動により大気中に放出され,大きな温室効果をもつ気体である.年々大気中の濃度は増加しており,一酸化窒素とともに大気汚染物質としての窒素酸化物(NOx)のおもなものである.高温では分解して酸素を放出し,金属,炭素,硫黄,リンなどとはげしく反応する.水に多少溶けるが次亜硝酸とはならない.麻酔性をもち,吸入すると顔の筋肉をけいれんさせ,笑ったように見えるので笑気ともよばれる.吸入麻酔薬として用いられる.また,半導体の製造にも用いられる.森北出版「化学辞典(第2版)

用途そのまま、又は酸素と混ぜて歯科及び外科、産婦人科の麻酔用に多く用いられる。また漏えい検知用、冷媒、原子吸光のキャリアガスにも用いられる。食品添加物(ホイップクリーム類の起泡剤)

説明dinitrogen monoxide’s (N2O) common name is nitrous oxide.Nitrous oxide is a colorless, nonfl ammable, nontoxic gas with a slightly sweet odor and taste. Nitrous oxide is produced by the thermal decomposition of ammonium nitrate at approximately 240°C: NH4NO3(g) → N2O(g) + 2H2O(g).Nitrous oxide is an important greenhouse gas. Its atmospheric residence time is 120 years. A molecule of N2O has 310 times the potential for absorbing heat compared to a molecule of CO2. Nitrous oxide is stable and unreactive on the earth’s surface, but it can be transported to the stratosphere where it absorbs energy and is converted into reactive forms of nitrogen such as nitric oxide and the nitrate radical contributing to ozone destruction.

来歴nitrous oxide was prepared in 1772 by Joseph Priestley (1733 1804) . Priestley called nitric oxide nitrous air, nitrogen dioxide nitrous acid vapor, and nitrous oxide phlogisticated nitrous air, but also referred to the dioxide. Priestley prepared nitric oxide by reacting nitric acid with a metal such as copper: 3Cu(s) + 8HNO3(aq) 2NO(g) + 3Cu(NO3)2(aq) + 4H2O(l).He prepared nitrous oxide by reducing nitric oxide using iron: 2NO(g) + H2O(l) + Fe(s) N2O(g) + Fe(OH)2(aq).For example, the year of discovery for nitrous oxide ranges between 1772 and 1793. Humphrey Davy (1778 1829) examined the physiological effects of nitrous oxide and in 1799 wrote Researches Chemical and Philosophical, Chiefly Concerning Nitrous Oxide.

使用Nitrous oxide was discovered by Priestley. It is found in the atmosphere in trace concentrations. The gas is used as an anesthetic, especially in dentistry and minor surgery. It produces mild hysteria and laughter preceding the anesthetic effect, for which reason it also is called “laughing gas.” It is used as an aerosol propellant, an aerating agent for whipped cream, and an oxidizing agent at high temperatures. Nitrous oxide also is used in the preparation of nitrites and as a flame gas in flame atomic absorption spectrometry of metals.

一般的な説明NITROUS OXIDE is a colorless, sweet-tasting gas. NITROUS OXIDE is also known as "laughing gas". Continued breathing of the vapors may impair the decision making process. NITROUS OXIDE is noncombustible but NITROUS OXIDE will accelerate the burning of combustible material in a fire. NITROUS OXIDE is soluble in water. Its vapors are heavier than air. Exposure of the container to prolonged heat or fire can cause NITROUS OXIDE to rupture violently and rocket. NITROUS OXIDE is used as an anesthetic, in pressure packaging, and to manufacture other chemicals.

使用用途亜酸化窒素は、歯科及び外科、産婦人科の麻酔に多く用いられます。半導体用材料や原子吸光分析用キャリアガスなど工業用にも使用されるほか、漏えい検知、冷媒、風船やタイヤへのガス充填にも使われます。 スペインの有名レストランがソーダサイフォンを使って食品に亜酸化窒素ガスを添加し、空気のように軽い泡の料理を開発しました。亜酸化窒素ガスを食品添加物扱いとし、液状の食材に亜酸化窒素を混ぜてムース状にする料理法をエスプーマと呼びます。日本でも流行した料理法です。 また、亜酸化窒素ガスは大気よりも酸素の存在比率が大きく、熱分解した時に大気よりも酸素分圧の高い混合気体が得られます。そのため、レース車のエンジンなどの内燃機関のブースト用に用いられる場合もあります。

調製方法 · 4 件

製造方法Prepared by thermal decomposition of ammonium nitrate NH4NO3 → N2O↑ + 2H2O

Nitrous oxide is prepared by heating ammonium nitrate to about 170°C. This reaction also forms water.

製造方法亜酸化窒素の工業的な製造方法としては、の熱分解法、アンモニア酸化法、法の3通りがあります。 1. 硝酸アンモニウムの熱分解法 硝酸アンモニウム熱分解法は、約250℃に保持した反応槽に原料の80%硝酸アンモニウム水溶液を、一定流量で滴下しながら分解させて亜酸化窒素を得る方法です。反応によって得られたガスは亜酸化窒素純度97~98%であり、不純物として、窒素、アンモニア、酸化窒素、を含みます。 この粗製亜酸化窒素ガスから水を冷却器で凝縮留去後、強アルカリ水溶液、強酸で洗浄することにより、不純物が除去された精製亜酸化窒素が得られます。 2. アンモニア直接酸化法 アンモニア直接酸化法はアンモニアを触媒により酸化して亜酸化窒素を得る方法です。反応生成物中の亜酸化窒素濃度が低いことと、触媒の寿命が短いことがプロセス上の課題でしたが、触媒の改良により現在は工業化されています。 不純物を含む粗製亜酸化窒素ガスを加圧下で水に吸収させ、減圧下で水より放散させることにより、酸素、窒素を分離して高純度の亜酸化窒素を得ます。 3. スルファミン酸法 スルファミン酸法はスルファミン酸と硝酸を80~100℃で反応させて亜酸化窒素を得る方法です。 NH2SO3H + HNO3 → N2O + H2SO4 + H2O

純化方法Wash the gas with concentrated alkaline pyrogallol solution, to remove O2, CO2, and NO2, then dry it by passing it through columns of P2O5 or Drierite, and collecting in a dry trap cooled in liquid N2. It is further purified by freeze-pump-thaw and distillation cycles under vacuum [Ryan & Freeman J Phys Chem 81 1455 1977, Schenk in Handbook of Preparative Inorganic Chemistry (Ed. Brauer) Academic Press Vol I pp 484-485 1963].

補足説明 · 1 件

定義ChEBI: A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with ts non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.

関連反応

0 件

現在のフィルター条件では反応記録がありません。

関連ノート

読み込み中…